Journal ArticleOPEN ACCESS

Mpox Epidemiology and Vaccine Effectiveness, England, 2023.

  • Charles H
  • Thorley K
  • Turner C
  • et al.
Emerging infectious diseases (2024) 30(10)
DOI: 10.3201/eid3010.240292
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Reported mpox cases in England continued at a low but steady frequency during 2023. Of 137 cases reported in 2023, approximately half were acquired overseas and half were in vaccinated persons. Estimated effectiveness of 2-dose vaccine was 80%, and no vaccinated mpox patient was hospitalized.

Cite

CITATION STYLE

APA

Charles, H., Thorley, K., Turner, C., Bennet, K. F., Andrews, N., Bertran, M., … Sinka, K. (2024). Mpox Epidemiology and Vaccine Effectiveness, England, 2023. Emerging Infectious Diseases, 30(10). https://doi.org/10.3201/eid3010.240292

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free